Permanent Left Bundle Branch Area Pacing for High-Degree Atrioventricular Block in a 6-Year-Old Child with 2-Year

Juan Hua1, Qinmei Xiong1, Zhen Xia1

  • 1Department of Cardiology, The Second Affiliated Hospital of Nanchang University.

International Heart Journal
|September 14, 2022
PubMed

Insights

Left bundle branch area pacing (LBBAP) is a safe and feasible pacing option for pediatric patients with atrioventricular block (AVB). This study shows stable electrical parameters and no complications at a 2-year follow-up, suggesting LBBAP as a viable alternative.

Area of Science:

  • Cardiology
  • Pediatric Electrophysiology
  • Medical Devices

Background:

  • Limited data exists on the safety and feasibility of left bundle branch area pacing (LBBAP) in pediatric patients with atrioventricular block (AVB).
  • Existing literature primarily consists of case reports with short-term follow-up periods (3 months to 1 year).

Observation:

  • A 6-year-old child with high-degree AVB, secondary to transcatheter device closure of a congenital ventricular septal defect, underwent successful LBBAP.
  • The patient experienced no procedure-related complications, and pacing parameters remained stable throughout the 2-year follow-up period.
  • A systematic literature review identified 15 pediatric cases of LBBAP, with no reported complications.

Findings:

  • Left bundle branch area pacing (LBBAP) demonstrated feasibility and safety in a pediatric case with a 2-year follow-up.
  • The systematic review of 15 pediatric cases revealed no reported complications associated with LBBAP.
  • Electrical parameters remained stable, indicating the long-term efficacy of LBBAP in this pediatric population.

Implications:

  • Left bundle branch area pacing (LBBAP) may serve as a viable alternative pacing strategy for pediatric patients, even from a very young age.
  • Further research is warranted to investigate the long-term outcomes and establish LBBAP as a standard pacing modality in children.
  • The findings support the consideration of LBBAP in pediatric cases of atrioventricular block, pending more extensive long-term data.